A PhD from University of Rochester, Xitong co-founded InKaryo in April 2013 and led the development of eKaryotype product. Prior to InKaryo, Xitong was director of bioinformatics and led the sequencing analysis for prenatal verifi™ test at Verinata Health (acquired by Illumina). Prior to that, Xitong built and led bioinformatics team at Genomic Health for cancer diagnostics. He also worked at Ingenuity Systems, PPD Inc, Novartis, and MIT.

A PhD from Cornell University with postdoctoral training from UCSF, Katie is an enthusiast in translating biological sciences to clinical products at InKaryo. She developed next generation sequencing method for RNA expression profiling and genotyping at UCSF. Katie has been a frequent speaker at various research institutions, conferences, scientific forums, and co-authored many high impact publications in molecular genetics.